EUVIMEDEUVIMED entdecken
Crossref

Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model

Lu Liu

Pakistan Journal of Pharmaceutical Sciences · 09.11.2026

DOI: 10.36721/pjps/2026.40.16885.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 09.11.2026. Verfasst von Lu Liu. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sepsis-induced cardiomyopathy (SICM), a significant cardiovascular complication of sepsis, necessitates prompt and effective management. While timely antimicrobial treatment forms the bedrock of early sepsis management, the relationship between the timing of piperacillin/tazobactam administration and the development of SICM remains incompletely characterized.

Objectives

The primary objective of this study was to investigate the association between early piperacillin/tazobactam administration and SICM incidence and short-term outcomes. A secondary objective was to identify factors associated with SICM and to develop an exploratory model for its prediction.

Methods

This single-center, retrospective observational study included 149 adults with sepsis admitted between January 2023 and January 2026. Patients were categorized into two groups: Early treatment (≤1 h; n=68) or delayed treatment (>1 h; n=81). SICM was assessed using echocardiographic criteria. Clinical outcomes were compared using univariate and multivariable logistic regression. Internal validation was performed using 1,000 bootstrap resamples.

Results

SICM occurred in 15/68 (22.06%) early-treatment patients and 33/81 (40.74%) delayed-treatment patients (P=0.014). Twenty-eight-day mortality was 14.71% versus 29.63% (P=0.029) and ICU and total hospital stays were shorter in the early-treatment group (both P

Zitieren

APA

Liu, L. (2026). Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16885.1

Vancouver

Liu L. Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16885.1

BibTeX
@article{Liu2026,
  author = {Liu, Lu},
  title = {Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model},
  journal = {Pakistan Journal of Pharmaceutical Sciences},
  year = {2026},
  doi = {10.36721/pjps/2026.40.16885.1}
}
Kostenlos starten →